Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELOTUZUMAB Cause Blood creatinine increased? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Blood creatinine increased have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.4% of all adverse event reports for ELOTUZUMAB.

14
Reports of Blood creatinine increased with ELOTUZUMAB
0.4%
of all ELOTUZUMAB reports
3
Deaths
5
Hospitalizations

How Dangerous Is Blood creatinine increased From ELOTUZUMAB?

Of the 14 reports, 3 (21.4%) resulted in death, 5 (35.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does ELOTUZUMAB Cause?

Plasma cell myeloma (339) Death (234) Malignant neoplasm progression (227) Pneumonia (209) Pyrexia (183) Drug ineffective (137) Neutropenia (133) Anaemia (119) Thrombocytopenia (107) Diarrhoea (105)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which ELOTUZUMAB Alternatives Have Lower Blood creatinine increased Risk?

ELOTUZUMAB vs ELOXATIN ELOTUZUMAB vs ELRANATAMAB ELOTUZUMAB vs ELRANATAMAB-BCMM ELOTUZUMAB vs ELTROMBOPAG ELOTUZUMAB vs ELTROMBOPAG OLAMINE

Related Pages

ELOTUZUMAB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased ELOTUZUMAB Demographics